Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: a randomized, double-blind, placebo-controlled European study.
作者:
发布时间
2013-11-20
- 浏览15

Journal of Infection
42-48页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文